Thierry Lafont

746 total citations
24 papers, 607 citations indexed

About

Thierry Lafont is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Thierry Lafont has authored 24 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 5 papers in Molecular Biology. Recurrent topics in Thierry Lafont's work include Cancer Treatment and Pharmacology (6 papers), Chemotherapy-induced organ toxicity mitigation (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Thierry Lafont is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Chemotherapy-induced organ toxicity mitigation (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Thierry Lafont collaborates with scholars based in France, United Kingdom and Netherlands. Thierry Lafont's co-authors include Étienne Chatelut, Lionel Rostaing, Nassim Kamar, Florent Puisset, Jacques Izopet, Cécile Arellano, Efthymios Manolis, Peggy Gandia, Fabienne Thomas and Jean‐Pierre Delord and has published in prestigious journals such as Journal of Clinical Oncology, Pharmaceutical Research and American Journal of Kidney Diseases.

In The Last Decade

Thierry Lafont

23 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thierry Lafont France 15 197 113 107 94 91 24 607
Aya Nakaya Japan 13 290 1.5× 102 0.9× 39 0.4× 71 0.8× 154 1.7× 54 601
Rosa Ayala Spain 19 207 1.1× 358 3.2× 78 0.7× 239 2.5× 425 4.7× 92 940
Jason B. Litten United States 9 132 0.7× 202 1.8× 102 1.0× 22 0.2× 16 0.2× 21 537
E. Winton United States 13 148 0.8× 112 1.0× 19 0.2× 88 0.9× 403 4.4× 23 608
K C Lakshmaiah India 11 315 1.6× 105 0.9× 85 0.8× 20 0.2× 26 0.3× 28 544
Salah Aref Egypt 16 180 0.9× 304 2.7× 46 0.4× 124 1.3× 341 3.7× 90 831
Nicolas Martin France 14 244 1.2× 46 0.4× 107 1.0× 122 1.3× 75 0.8× 50 711
Dawn J. Caster United States 13 50 0.3× 102 0.9× 111 1.0× 20 0.2× 33 0.4× 33 694
C.G. Alexopoulos Greece 15 421 2.1× 148 1.3× 118 1.1× 24 0.3× 48 0.5× 34 789

Countries citing papers authored by Thierry Lafont

Since Specialization
Citations

This map shows the geographic impact of Thierry Lafont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Lafont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Lafont more than expected).

Fields of papers citing papers by Thierry Lafont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Lafont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Lafont. The network helps show where Thierry Lafont may publish in the future.

Co-authorship network of co-authors of Thierry Lafont

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Lafont. A scholar is included among the top collaborators of Thierry Lafont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Lafont. Thierry Lafont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arellano, Cécile, Christelle Vachoux, Christine Chevreau, et al.. (2022). Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induced Liver Injury. Metabolites. 12(9). 852–852. 3 indexed citations
2.
Chevreau, Christine, Aude Fléchon, R. Delva, et al.. (2020). Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors. Pharmaceutical Research. 37(7). 147–147. 4 indexed citations
3.
Obéric, Lucie, Stanislas Faguer, Suzanne Tavitian, et al.. (2020). Body Surface Area Dosing of High-Dose Methotrexate Should Be Reconsidered, Particularly in Overweight, Adult Patients. Therapeutic Drug Monitoring. 43(3). 408–415. 12 indexed citations
4.
Alix‐Panabières, Catherine, Thierry Lafont, Ben Allal, et al.. (2019). Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients. British Journal of Clinical Pharmacology. 85(6). 1357–1366. 19 indexed citations
5.
Thomas, Fabienne, Gareth J. Veal, Souleiman El Balkhi, et al.. (2018). Therapeutic drug monitoring and dose adaptation of cisplatin in a newborn with hepatoblastoma: a case report. Cancer Chemotherapy and Pharmacology. 82(2). 361–365. 7 indexed citations
6.
Puisset, Florent, et al.. (2018). Simultaneous monitoring of pazopanib and its metabolites by UPLC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 154. 373–383. 12 indexed citations
7.
Beauvais, David, Ben Allal, Thierry Lafont, et al.. (2018). Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluid. Journal of Chromatography B. 1093-1094. 158–166. 29 indexed citations
8.
Dièras, Véronique, Thomas Bachelot, Mario Campone, et al.. (2016). Pharmacokinetic interaction between pazopanib and cisplatin regimen. Cancer Chemotherapy and Pharmacology. 77(2). 385–392. 12 indexed citations
9.
Négrier, Sylvie, Helen Powell, Thierry Lafont, et al.. (2015). Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site. Investigational New Drugs. 34(1). 41–48. 25 indexed citations
10.
Négrier, Sylvie, Philippe A. Cassier, Antoine Hollebecque, et al.. (2014). Pharmacokinetics of pazopanib administered in combination with bevacizumab. Cancer Chemotherapy and Pharmacology. 73(6). 1189–1196. 17 indexed citations
11.
Puisset, Florent, Mélanie White‐Koning, Nassim Kamar, et al.. (2013). Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody‐mediated disease. British Journal of Clinical Pharmacology. 76(5). 734–740. 59 indexed citations
12.
Gandia, Peggy, et al.. (2012). Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?. Cancer Chemotherapy and Pharmacology. 71(2). 531–536. 25 indexed citations
13.
Arellano, Cécile, et al.. (2012). Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLC–MS/MS assay and ultrafiltration method. Journal of Chromatography B. 907. 94–100. 35 indexed citations
14.
Nicot, Florence, Florence Abravanel, Thierry Lafont, et al.. (2008). Serum concentrations of ribavirin and pegylated interferon and viral responses in patients infected with HIV and HCV. Journal of Medical Virology. 80(9). 1523–1529. 29 indexed citations
15.
Ferron, Gwénaël, Laurence Gladieff, Jean‐Pierre Delord, et al.. (2007). Pharmacokinetics of heated intraperitoneal oxaliplatin. Cancer Chemotherapy and Pharmacology. 62(4). 679–683. 30 indexed citations
16.
Puisset, Florent, Étienne Chatelut, Alex Sparreboom, et al.. (2006). Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect. Cancer Chemotherapy and Pharmacology. 60(2). 305–308. 11 indexed citations
17.
Thomas, Fabienne, Laurence Gladieff, Florence Dalenc, et al.. (2005). Cystatin C as a New Covariate to Predict Renal Elimination of Drugs. Clinical Pharmacokinetics. 44(12). 1305–1316. 32 indexed citations
18.
Puisset, Florent, Étienne Chatelut, Florence Dalenc, et al.. (2004). Dexamethasone as a probe for docetaxel clearance. Cancer Chemotherapy and Pharmacology. 54(3). 265–72. 53 indexed citations
19.
Kamar, Nassim, Étienne Chatelut, Efthymios Manolis, et al.. (2004). Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function. American Journal of Kidney Diseases. 43(1). 140–146. 64 indexed citations
20.
Delord, Jean‐Pierre, Rosine Guimbaud, Nicolas Grégoire, et al.. (2002). Population pharmacokinetics of oxaliplatin. Cancer Chemotherapy and Pharmacology. 51(2). 127–131. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aya Nakaya Breakdown of academic impact, for papers by Rosa Ayala Breakdown of academic impact, for papers by Jason B. Litten Breakdown of academic impact, for papers by E. Winton Breakdown of academic impact, for papers by K C Lakshmaiah Breakdown of academic impact, for papers by Salah Aref Breakdown of academic impact, for papers by Nicolas Martin Breakdown of academic impact, for papers by Dawn J. Caster Breakdown of academic impact, for papers by C.G. Alexopoulos
Rankless by CCL
2026